BSE Live
Oct 17, 16:01Prev. Close
194.30
Open Price
194.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 16:01Prev. Close
194.16
Open Price
194.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
192.64 (57)
Balance Sheet of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 13 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 1,324.35 | 1,322.95 | 1,193.32 | 1,185.91 | 994.60 | |
Total Share Capital | 1,324.35 | 1,322.95 | 1,193.32 | 1,185.91 | 994.60 | |
Reserves and Surplus | 6,128.19 | 5,389.12 | 4,068.47 | 3,881.43 | 3,105.92 | |
Total Reserves and Surplus | 6,128.19 | 5,389.12 | 4,068.47 | 3,881.43 | 3,105.92 | |
Total Shareholders Funds | 7,452.54 | 6,712.07 | 5,261.79 | 5,067.34 | 4,100.62 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 356.84 | 363.94 | 592.34 | 447.61 | 0.00 | |
Deferred Tax Liabilities [Net] | 213.13 | 196.64 | 194.15 | 157.54 | 170.42 | |
Other Long Term Liabilities | 14.27 | 18.18 | 22.25 | 7.95 | 7.37 | |
Long Term Provisions | 48.56 | 32.23 | 20.58 | 10.74 | 6.59 | |
Total Non-Current Liabilities | 632.80 | 610.99 | 829.32 | 623.84 | 184.38 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 865.09 | 787.95 | 1,034.94 | 653.92 | 165.20 | |
Trade Payables | 1,184.76 | 1,107.71 | 761.67 | 615.20 | 584.12 | |
Other Current Liabilities | 213.79 | 288.59 | 115.47 | 215.52 | 691.47 | |
Short Term Provisions | 42.85 | 43.57 | 39.21 | 32.50 | 30.88 | |
Total Current Liabilities | 2,306.49 | 2,227.82 | 1,951.29 | 1,517.14 | 1,471.67 | |
Total Capital And Liabilities | 10,391.83 | 9,550.88 | 8,042.40 | 7,208.32 | 5,756.67 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 2,128.82 | 1,850.58 | 1,796.06 | 1,309.96 | 1,305.23 | |
Intangible Assets | 765.46 | 761.58 | 805.81 | 299.02 | 321.58 | |
Capital Work-In-Progress | 77.68 | 232.40 | 136.50 | 155.28 | 79.34 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 3,221.58 | 3,145.40 | 3,018.44 | 1,814.08 | 1,747.81 | |
Non-Current Investments | 3,105.31 | 1,646.88 | 1,646.87 | 2,597.28 | 1,591.52 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 456.57 | 1,395.19 | 970.65 | 791.65 | 613.81 | |
Other Non-Current Assets | 72.49 | 71.86 | 57.76 | 46.82 | 36.03 | |
Total Non-Current Assets | 6,855.95 | 6,259.33 | 5,693.72 | 5,249.83 | 3,989.17 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 61.28 | 100.12 | 37.01 | 0.00 | |
Inventories | 1,205.35 | 1,153.04 | 818.61 | 481.28 | 420.88 | |
Trade Receivables | 1,666.69 | 1,331.38 | 909.56 | 947.65 | 839.75 | |
Cash And Cash Equivalents | 177.84 | 241.73 | 64.16 | 90.27 | 152.35 | |
Short Term Loans And Advances | 12.52 | 47.24 | 34.09 | 47.32 | 10.60 | |
OtherCurrentAssets | 473.48 | 456.88 | 422.14 | 354.96 | 343.92 | |
Total Current Assets | 3,535.88 | 3,291.55 | 2,348.68 | 1,958.49 | 1,767.50 | |
Total Assets | 10,391.83 | 9,550.88 | 8,042.40 | 7,208.32 | 5,756.67 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 200.65 | 190.29 | 150.70 | 101.97 | 75.22 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 949.61 | 956.01 | 673.35 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 3,640.07 | 2,685.06 | 2,047.79 | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 177.67 | 177.67 | 177.67 | 177.67 | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 3,105.31 | 1,646.88 | 1,646.83 | 2,597.28 | 1,591.52 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | 37.01 | -- |
31.07.2025
30.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
14.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
19.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Consolidated March 2025 Net Sales at Rs 2,754.07 crore, up 7.9% Y-o-Y